Cisztás fibrózis: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• CFTR 29
• GLP-1 2
• G6PD 0
• IL-13 0
• MUC1 0
• NF1 1
• PDE4 0
• STAT3 0
• CTNNB1 0
• DMD 1
• EGFR 0
• ERK 0
• HDAC 0
• HMGB1 0
• HTT 1
• IL-1 0
• IL-17 0
• IL-4 0
• IL-6 0
• mTOR 0
• NLRP3 0
• NRF2 0
• PKD1 0
• PPAR 0
• SGLT2 0
• SMN1 1
• TLR4 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Discovery and evolution of CRISPR-Associated Transposons (CAST) for functional RNA-guided integration (CRAFT)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 263 393 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  A doctoral training programme for next-generation LUNG-targeted non-viral GENEtic MEDicines (LUNG-GENEMED)

  Politecnico di Milano· Milano, Olaszország· EU contribution 3 876 613 EUR· until 2030. nov.· 7 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Maternal human milk as a Risk factor to the Early-life Exposome (MATREEX)

  King's College London· London, Egyesült Királyság· EU contribution 345 235 EUR· until 2029. febr.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  In vitro and in situ structural characterization of the biofilm-associated functional amyloids in Pseudomonas aeruginosa bacteria (FAPbulous)

  Deutsches Elektronen-Synchrotron Desy· Hamburg, Németország· EU contribution 202 125 EUR· until 2027. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  CellCourier: programmable drug delivery via combinatorial cell targeting and generative design of tailored binding peptides

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 150 000 EUR· until 2027. jún.

  The disease is named only in the funder's project summary, not in the title.

5 of 11 running projects, newest first. Listed amounts together: 19,9 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 5
• Organoids 20
• CRISPR-Cas Systems 12
• Gene Expression Profiling 13
• Sequence Analysis, RNA 2
• Whole Genome Sequencing 16
• Exome Sequencing 5
• Proteomics 12
• Metabolomics 9
• Mass Spectrometry 4
• Flow Cytometry 2
• Immunohistochemistry 3
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 21
• Machine Learning 6
• Deep Learning 3
• Cohort Studies 37
• Genome-Wide Association Study 3

• Integrated expression profiling reveals molecular crosstalk between CFTR, FASN, FRAP (mTOR), and BANK1 in hepatocellular carcinoma.

  Sci Rep, 2026. szept.

• Induction of the filamentous prophage, Pf4, is conditionally regulated by PA3572 (difP) in Pseudomonas aeruginosa biofilms.

  Microbiology (Reading), 2026. szept.

• Discovery of Staphylococcus aureus small RNAs highly expressed during human chronic infection.

  mBio, 2026. aug.

• Mucin-induced metabolic reprogramming in Pseudomonas aeruginosa clinical isolates.

  mSystems, 2026. júl.

• Single-cell profiling of BAL in preschool cystic fibrosis reveals macrophage dysregulation and ivacaftor-modified inflammatory programs in the early life lung.

  Mucosal Immunol, 2026. márc.

• Host transcriptomic analysis reveals a defective intracellular environment that limits SARS-CoV-2 replication in CFTR-deficient airway epithelium.

  Front Cell Infect Microbiol, 2026. márc.

• Single-cell RNAseq identifies persistent epithelial and immune dysfunction in PwCF by mitigating inter-individual sampling heterogeneity.

  J Cyst Fibros, 2026. márc.

• Computational framework for therapeutic target discovery via perturbation simulation: application to cystic fibrosis airway disease.

  Brief Bioinform, 2026. márc.

• The longitudinal expression of P. aeruginosa reference genes in infection-mimicking media.

  Microbiology (Reading), 2026. jan.

• Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejection.

  EBioMedicine, 2025. dec.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.